A carregar...
Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report
INTRODUCTION: sorafenib, a tyrosine-kinase inhibitor, is widely used in the treatment of advanced hepatocellular carcinoma. Drug-related toxicities are generally mild but sorafenib, as other similar agents, may induce elevation of systemic arterial blood pressure levels in relation to an interaction...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2803930/ https://ncbi.nlm.nih.gov/pubmed/20062650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-1626-2-9133 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|